Pediatric Trials

Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy

Study to focus on the defining and managing the neuropsychological abnormalities of myotonic dystrophy and to find out if the neuropsychological abnormalities have any correlation with changes seen on Magnetic Resonance Imaging.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - 20 subjects with Myotonic Dystrophy type 1 aged 8 to 17 years and 20 controls who are
   healthy volunteers or siblings of affected subjects.

Exclusion Criteria:

Ages Eligible for Study

8 Years - 17 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
John W Day, MD, PhD
650-725-4341
Recruiting